Publications by authors named "B Liebl"
Aspirin-triggered lipoxin A4 reduces neuropathic pain and anxiety-like behaviours in male diabetic rats: antinociceptive enhancement by cannabinoid receptor agonists.
Eur J Pharmacol
February 2025
Neuropathy is the most common complication of diabetes, leading to painful symptoms like hyperalgesia. Current treatments for diabetic painful neuropathy often prove inadequate, necessitating the exploration of new pharmacological approaches. Therefore, this study aimed to investigate the potential antinociceptive effect of aspirin-triggered lipoxin A4 (ATL), a specialized pro-resolving lipid mediator, when administered alone or in combination with cannabinoid agonists, to alleviate diabetic neuropathic pain.
View Article and Find Full Text PDFBackground: Traumatic brain injury (TBI) management guidelines vary across regions and there is limited research on real-world adherence to these guidelines. We conducted a global survey to assess the adherence of neurosurgeons to TBI guidelines and evidence-based medicine (EBM).
Method: A 24-item survey was created using Google Forms, covering demographic information, neurotrauma training, basic knowledge of EBM, surgical and in-hospital management.
Article Synopsis
- The study examined how two-dose COVID-19 vaccinations impact symptoms and immune response in individuals infected with SARS-CoV-2 variants of concern (VOC) like Alpha and Delta, focusing on breakthrough infections (BTIs).
- It included 300 participants (212 with BTIs, 88 without) from Bavaria, Germany, who were assessed weekly for symptoms, viral load, and antibody response following their infections.
- Results showed that vaccinated individuals experienced significantly fewer symptoms and had a stronger immune response compared to unvaccinated individuals, supporting the idea that full vaccination can mitigate the severity of infections caused by emerging virus variants.
[Bavarian online database for corona screening tests-development and use of a digital solution in the pandemic].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
February 2023
During the SARS-CoV‑2 pandemic, various data had to be collected to support political decisions for pandemic preparedness and response. Nevertheless, using analogue tools like paper and pencil as well as sending files with media discontinuity that have to be merged later are not useful and can hardly provide usable data in real time. With the selected system architecture, the Bavarian Online Database for Corona Screening Tests (BayCoRei) is a central, Bavaria-wide, consistent digital solution that is agile and easy to use.
View Article and Find Full Text PDFBackground: Despite a vaccination rate of 82.0% (n = 123/150), a SARS-CoV-2 (Alpha) outbreak with 64.7% (n = 97/150) confirmed infections occurred in a nursing home in Bavaria, Germany.
View Article and Find Full Text PDF